Results 171 to 180 of about 146,739 (334)
ABSTRACT Desmopressin (DDAVP), which indirectly increases Coagulation Factor VIII concentrations in the blood, is a common treatment for bleeding disorders such as von Willebrand disease or hemophilia A. However, DDAVP exhibits significant variability in response due to interindividual differences in pharmacokinetics.
Sophie Hodin+7 more
wiley +1 more source
Von Willebrand disease (VWD) and pregnancy: a comprehensive overview. [PDF]
Soleimani Samarkhazan H+5 more
europepmc +1 more source
How I treat patients with von Willebrand disease [PDF]
Pier Mannuccio Mannucci
openalex +1 more source
Bleeding Complications in JAK2‐Variant Essential Thrombocythemia: A Revisit in 2025
ABSTRACT Essential thrombocythemia (ET) is a myeloproliferative neoplasm characterised by sustained thrombocytosis. Paradoxically, bleeding complications remain an under‐recognised clinical challenge. Compared with CALR‐mutated patients, those harbouring the JAK2‐V617F variant appear more prone to haemorrhage.
Gerard Gurumurthy+4 more
wiley +1 more source
Clinical spectrum of hepatitis C‐related liver disease and response to treatment with interferon and ribavirin in haemophilia or von Willebrand disease [PDF]
Stefan Lethagen+4 more
openalex +1 more source
Willebrand factor in von Willebrand's disease. [PDF]
F E Boulton, M J Lloyd
openaire +3 more sources
ABSTRACT Objectives The present study investigated the effects of thrombosis, hemorrhagic events, disease progression, and secondary malignancies on patient survival after the diagnosis of essential thrombocythemia (ET). Methods We analyzed data from 1152 patients enrolled in the JSH‐MPN‐18 study using time‐dependent Cox regression and multistate ...
Yoshinori Hashimoto+24 more
wiley +1 more source